Clone B38 was isolated from a COVID-19 patient and it was subsequently shown to neutralize SARS-CoV-2, in vitro, by blocking the interaction between the SARS-CoV-2 S-RBD and the host receptor ACE2 [18]. The gene discussed is ACE2; the disease is COVID-19.